Pascoe Pharmazeutische Praeparate GmbH
16
1
1
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
18.8%
3 terminated/withdrawn out of 16 trials
78.6%
-7.9% vs industry average
25%
4 trials in Phase 3/4
73%
8 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
A Long-term Observational Study to Describe the Use of Vitamin-C Injektopas® 7.5 g in Patients With Vitamin C Deficiency
Role: lead
Vitamin C as add-on Therapy in Patients With Acute Herpes Zoster
Role: lead
Treatment of Patients Suffering From Nervous Restlessness With PASCOFLAIR®
Role: lead
A Long-term Study to Describe the Use of PASCORBIN® 7.5 g in Patients With Vitamin C Deficiency
Role: lead
Effectiveness of NEURAPAS Balance in Children With Nervous Restlessness
Role: lead
Pharmacological Effects of Pascoflair® on Brain Activity in Patients Suffering From Test Anxiety
Role: lead
Observational Study With PASCALLERG ® in Patients With Hay Fever
Role: lead
Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles
Role: lead
Pilot Study on the Efficacy of Pascoflair in an Acute Stressful Situation (TSST)
Role: lead
PASCOE-Agil HOM-Injektopas in the Treatment of Rheumatic Disorders
Role: lead
PASCONAL NERVENTROPFEN in the Treatment of Nervous Diseases
Role: lead
Efficacy and Safety of Lymphdiaral Basistropfen (HDC) in the Treatment of Chronic Low-back Pain
Role: lead
Trial Evaluating Devil's Claw for the Treatment of Hip and Knee Osteoarthritis
Role: collaborator
Study to Investigate Effects of a Herbal Drug Compared to Placebo on Sleep
Role: lead
Study of the Antidepressant Efficacy of a Combination Herbal Drug Preparation (NEURAPAS Balance)
Role: lead
Pharmacological Effects of Neurapas® Balance and Pascoflair® 425 mg on Brain Activity in Healthy Volunteers
Role: lead
All 16 trials loaded